← Back to Search

Behavioural Intervention

Sleep and Exercise for Alzheimer's Disease (CASE Trial)

N/A
Recruiting
Led By Azizi A Seixas, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-reported history of problems with cognitive impairment: memory, concentration, and processing information
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to week 12
Awards & highlights

CASE Trial Summary

This trial will look at the effects of exercise and sleep on cognitive function and whether heart health, sleep, or stress play a role in that.

Who is the study for?
This trial is for individuals experiencing memory, concentration, or information processing issues who can do mild exercise and wear a DREEM 2 Headband and Fitbit watch. They must be able to handle a digital device and perform the Everlywell biomarker test. Participants should speak English and consent willingly.Check my eligibility
What is being tested?
The study examines how sleep quality and an exercise routine might influence dementia risk over time using tools like the DREEM 2 Headband to monitor sleep patterns and a Fitbit watch to track activity levels.See study design
What are the potential side effects?
Potential side effects may include discomfort from wearing the headband or wristwatch devices continuously, skin irritation from prolonged device contact, muscle soreness from exercise routines, or stress related to blood sample collection.

CASE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have issues with memory, focusing, or understanding information.

CASE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Pressure
Cortisol Levels
Cortisone Levels
+11 more

CASE Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Sleep Only GroupExperimental Treatment1 Intervention
Participants in this group will wear the DREEM 2 headband for 12 weeks.
Group II: Exercise Only GroupActive Control1 Intervention
Participants in this group will workout twice a week for 12 weeks.
Group III: Exercise and Sleep GroupActive Control2 Interventions
Participants in this group will take part in a guided exercise program in additional to wearing the DREEM 2 headband for 12 weeks.

Find a Location

Who is running the clinical trial?

DreemIndustry Sponsor
6 Previous Clinical Trials
248 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,696 Total Patients Enrolled
16 Trials studying Dementia
67,064 Patients Enrolled for Dementia
University of MiamiLead Sponsor
901 Previous Clinical Trials
409,956 Total Patients Enrolled
7 Trials studying Dementia
28,104 Patients Enrolled for Dementia

Media Library

Exercise Routine (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04855630 — N/A
Dementia Research Study Groups: Sleep Only Group, Exercise Only Group, Exercise and Sleep Group
Dementia Clinical Trial 2023: Exercise Routine Highlights & Side Effects. Trial Name: NCT04855630 — N/A
Exercise Routine (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04855630 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for this trial?

"According to clinicaltrials.gov, the recruitment phase for this medical trial is now concluded. Initially posted on March 1st 2023 and last updated December 5th 2022, this study no longer seeks participants - however, there are 771 other trials actively recruiting at present."

Answered by AI

Does this medical trial accept applicants who are over 30 years of age?

"This medical study specifies that interested candidates must be between 45 and 80 years of age. There are 34 trials available to those under 18, while 759 exist for patients over the seniority threshold of 65."

Answered by AI

Is it feasible to sign up for this medical experiment?

"This trial seeks to recruit 30 participants aged between 45 and 80 suffering from dementia. In order to qualify, applicants must be able to complete the Everlywell biomarker procedure, comprehend English language, demonstrate a self-reported history of cognitive impairment such as memory deficits or difficulty concentrating, manage mild physical exercise routines, wear DREEM 2 Headband & Fitbit wrist watch simultaneously, and operate digital devices like mobile phones or computers with proficiency. Lastly only those mentally capable of granting consent will be considered for inclusion in the study."

Answered by AI

Who else is applying?

What site did they apply to?
NYU Langone Health
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I am currently taking Memantine 2x daily and Doneprazil (nightly).
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

How long do screening visits last?
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Combating Alzheimer's Through Sleep and Exercise
Azizi Seixas 2023. "Combating Alzheimer's Through Sleep and Exercise". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04855630.
All > Alzheimer Disease > Dementia
~12 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top